{"id":"ptp-01","safety":{"commonSideEffects":[]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"PTP-01 targets protein tyrosine phosphatases, which are negative regulators of T cell receptor signaling. By inhibiting these phosphatases, the drug enhances T cell activation and proliferation, potentially improving anti-tumor immune responses. This mechanism aims to overcome immune suppression in the tumor microenvironment.","oneSentence":"PTP-01 is a protein tyrosine phosphatase inhibitor that modulates immune cell signaling to enhance anti-tumor immunity.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T01:30:46.203Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Advanced solid tumors (Phase 3 development)"}]},"trialDetails":[{"nctId":"NCT07219771","phase":"PHASE3","title":"A Study to Evaluate the Efficacy and Safey of PTP-001 (MOTYS™) in Knee Osteoarthritis Patients","status":"RECRUITING","sponsor":"Doron Therapeutics Inc.","startDate":"2025-10-14","conditions":"Knee Osteoarthritis","enrollment":260},{"nctId":"NCT01962909","phase":"EARLY_PHASE1","title":"Phase 0 Biodistribution of Novel Imaging for Resectable Pancreatic Cancer","status":"TERMINATED","sponsor":"University of Virginia","startDate":"2013-11","conditions":"Pancreatic Ductal Adenocarcinoma","enrollment":3}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":1,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["MOTYS™","allogeneic human placental tissue particulate"],"phase":"phase_3","status":"active","brandName":"PTP-01","genericName":"PTP-01","companyName":"University of Virginia","companyId":"university-of-virginia","modality":"Small molecule","firstApprovalDate":"","aiSummary":"PTP-01 is a protein tyrosine phosphatase inhibitor that modulates immune cell signaling to enhance anti-tumor immunity. Used for Advanced solid tumors (Phase 3 development).","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":false,"trials":true,"score":3}}